Neoliberalism, State-Corporate Power and Regulatory Failure: The Harms of Prescription and Non-Prescription Medicine Regulation in Australia (Routledge Studies in Crime and Society) - Image 1

£151.26

It has never been this cheap. We have no record of a lower price.

£151 today · cheaper than every other day in the last 3 months

Routledge Neoliberalism, State-Corporate Power and Regulatory Failure: The Harms of Prescription and Non-Prescription Medicine Regulation in Australia (Routledge Studies in Crime and Society)

Name: Neoliberalism, State-Corporate Power and Regulatory Failure: The Harms of Prescription and Non-Prescription Medicine Regulation in Australia (Routledge Studies in Crime and Society)
Brand: Routledge
Price: 151.26 GBP
Availability: InStock

Public Health & Preventive Medicine

Price Distribution

Price distribution over 31 days • 1 price levels

Days at Price

Price Analysis

Most common price: £151 (31 days, 100.0%)

Price range: £151 - £151

Price levels: 1 different prices over 31 days

Description

Based on over a decade of research, this book examines the social harms of Australian prescription and non-prescription medicine regulation and how these ultimately stem from neoliberalism and its reinforcement of state and corporate power. Neoliberalism shapes state and corporate power, regulation and the harms resulting from regulatory failure, yet the links between these themes are rarely discussed. Drawing on the concept of hegemonic neoliberal governmentality, this book critically examines Australian medicine regulation and the harms resulting from its failure in areas such as medicine quality, safety and efficacy; direct-to-consumer advertising; and marketing directed at health professionals. It traces these harms through the colonial foundations and evolution of medicine regulation in Australia, exploring both regulatory failure and the attempts at reforming this regulatory system. It argues that neoliberalism is not regulatable and reinforces and sustains itself, empowering the state and corporations while disempowering the public and those representing its interests. Thus, reducing its harms is only achievable through broader, transformative change, rather than by reforming (and thereby continuing to work within) the existing neoliberal capitalist system. Neoliberalism, State-Corporate Power and Regulatory Failure will be of value to practitioners, members of the public and private sector and academics active in the fields of state, corporate and state–corporate crime, social harm and regulation, as well as to those new to the study of medicine-related harms. It will also be of interest to all those concerned about their health and the medicines they use.

Product Specifications

Brand: Routledge
Format: hardcover
ASIN: 1032259434
Category: Books > Subjects > Science, Nature & Maths > Medicine > Medical Sciences A-Z > Public Health & Preventive Medicine
Domain: Amazon UK
Release Date: 23 May 2025
Listed Since: 07 December 2024

Barcode

No barcode data available

It has never been this cheap. We have no record of a lower price.

Routledge Neoliberalism, State-Corporate Power and Regulatory Failure: The Harms of Prescription and Non-Prescription Medicine Regulation in Australia (Routledge Studies in Crime and Society)

Price Distribution

Price Analysis

Description

Product Specifications

Barcode

Similar Products You Might Like

The Routledge Handbook of the Political Economy of Health and Healthcare (Routledge International Handbooks)

Routledge Health 4.0 - Digital Transformation of Healthcare

The Regulation of Medical Products: Dope, Drugs and Devices (Law, Science and Society)

The Law of Off-label Uses of Medicines: Regulation and Litigation in the EU, UK and USA

Regulatory Protection in the Pharmaceutical and Life Science Industries: Challenges, Opportunities and Ongoing Reform (Elgar Monographs in Intellectual Property Law)

Health Policy Reform In China: A Comparative Perspective: Volume 36 (SERIES ON CONTEMPORARY CHINA)

Democratizing Health: Consumer Groups in the Policy Process

Illicit Medicines in the Global South: Public Health Access and Pharmaceutical Regulation (Routledge Global Health Series)

The Routledge Handbook of the Political Economy of Health and Healthcare (Routledge International Handbooks)

Guide to EU Pharmaceutical Regulatory Law

A Social History of Medicines in the Twentieth Century: To Be Taken Three Times a Day

Contagion Capitalism: Pandemics in the Corporate Age (The COVID-19 Pandemic Series)

Health Care Reform and Globalisation: The US, China and Europe in Comparative Perspective (Routledge Advances in Health and Social Policy)

Guide to U.S. Health and Health Care Policy

Global Pharmaceutical Policy: Ensuring Medicines for Tomorrow’s World

Doctors and Rules: A Sociology of Professional Values

Health Economics & Policy Challenges in Global Emerging Markets (Public Health in the 21st Century)

The Nature of Health: How America Lost, and Can Regain, a Basic Human Value

The Global Pharmaceutical Industry: The Demise and the Path to Recovery (Routledge Advances in Management and Business Studies)

Health Policy for Health Care Professionals

Guide to EU and UK Pharmaceutical Regulatory Law

Public and Private Roles in Health Care Systems: Experiences from Seven OECD Countries (State of Health)

European Regulation of Medical Devices and Pharmaceuticals: Regulatee Expectations of Legal Certainty

Research Handbook on EU Health Law and Policy (Research Handbooks in European Law series)

It has never been this cheap. We have no record of a lower price.

Routledge Neoliberalism, State-Corporate Power and Regulatory Failure: The Harms of Prescription and Non-Prescription Medicine Regulation in Australia (Routledge Studies in Crime and Society)

Price History & Forecast

Price Distribution

Price Analysis

Description

Product Specifications

Barcode

Similar Products You Might Like

The Routledge Handbook of the Political Economy of Health and Healthcare (Routledge International Handbooks)

Routledge Health 4.0 - Digital Transformation of Healthcare

The Regulation of Medical Products: Dope, Drugs and Devices (Law, Science and Society)

The Law of Off-label Uses of Medicines: Regulation and Litigation in the EU, UK and USA

Regulatory Protection in the Pharmaceutical and Life Science Industries: Challenges, Opportunities and Ongoing Reform (Elgar Monographs in Intellectual Property Law)

Health Policy Reform In China: A Comparative Perspective: Volume 36 (SERIES ON CONTEMPORARY CHINA)

Democratizing Health: Consumer Groups in the Policy Process

Illicit Medicines in the Global South: Public Health Access and Pharmaceutical Regulation (Routledge Global Health Series)

The Routledge Handbook of the Political Economy of Health and Healthcare (Routledge International Handbooks)

Guide to EU Pharmaceutical Regulatory Law

A Social History of Medicines in the Twentieth Century: To Be Taken Three Times a Day

Contagion Capitalism: Pandemics in the Corporate Age (The COVID-19 Pandemic Series)

Health Care Reform and Globalisation: The US, China and Europe in Comparative Perspective (Routledge Advances in Health and Social Policy)

Guide to U.S. Health and Health Care Policy

Global Pharmaceutical Policy: Ensuring Medicines for Tomorrow’s World

Doctors and Rules: A Sociology of Professional Values

Health Economics & Policy Challenges in Global Emerging Markets (Public Health in the 21st Century)

The Nature of Health: How America Lost, and Can Regain, a Basic Human Value

The Global Pharmaceutical Industry: The Demise and the Path to Recovery (Routledge Advances in Management and Business Studies)

Health Policy for Health Care Professionals

Guide to EU and UK Pharmaceutical Regulatory Law

Public and Private Roles in Health Care Systems: Experiences from Seven OECD Countries (State of Health)

European Regulation of Medical Devices and Pharmaceuticals: Regulatee Expectations of Legal Certainty

Research Handbook on EU Health Law and Policy (Research Handbooks in European Law series)